Dublin-listed healthcare services group Uniphar said 2022 saw strong performance for the group, with organic growth lifting profit despite the “uncertain, challenging period”.
In a trading update for the year, the group, which provides integrated services to more than 200 multinational pharmaceutical and medical technology manufacturers, said the business performed in line with the group’s expectations for 2022. Organic gross profit growth was more than 5 per cent, driven by organic growth across each division, along with the supply chain and retail division‘s outperformance.
The latter will likely be boosted in 2023 by the acquisition of McCauley’s Pharmacy Group, which was cleared earlier this month by competition authorities following the original announcement in September. The deal is expected to close imminently.
Source: Loan Digest (loandigest.net)
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: IrishTimes - 🏆 3. / 98 Read more »
Source: IrishTimes - 🏆 3. / 98 Read more »
Source: The42_ie - 🏆 5. / 86 Read more »
Source: IrishTimes - 🏆 3. / 98 Read more »
Irish start-up activity hits six-year low in 2022New figures from CRIFVision-net show that the number of company start-ups dropped by 16% in 2022 compared to the previous year.
Source: RTEbusiness - 🏆 16. / 61 Read more »
Ireland estimated to have had highest EU growth in 2022The economy grew by 3.5% in the last three months of last year, compared to the previous three months, according to an estimate by the Central Statistics Office.
Source: RTEbusiness - 🏆 16. / 61 Read more »